Victrex (LON:VCT) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why

Victrex plc (LON:VCT) passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 1,009.81 ($12.64) and traded as high as GBX 1,080 ($13.51). Victrex shares last traded at GBX 1,076 ($13.46), with a volume of 29,317 shares traded.

Analyst Ratings Changes

Separately, Berenberg Bank cut their target price on Victrex from GBX 1,290 ($16.14) to GBX 1,170 ($14.64) and set a “hold” rating on the stock in a research note on Wednesday, December 4th.

Victrex Stock Down 0.7 %

The firm’s 50 day simple moving average is GBX 962.42 and its 200 day simple moving average is GBX 1,007.81. The company has a market cap of £929.48 million, a price-to-earnings ratio of 3,051.43, a price-to-earnings-growth ratio of 1.92 and a beta of 0.69. The company has a quick ratio of 1.99, a current ratio of 5.30 and a debt-to-equity ratio of 16.99.

Victrex Increases Dividend

The firm also recently declared a dividend, which will be paid on Friday, February 21st. Shareholders of record on Thursday, January 23rd will be given a dividend of GBX 46.14 ($0.58) per share. This represents a yield of 5.26%. The ex-dividend date of this dividend is Thursday, January 23rd. This is a positive change from Victrex’s previous dividend of $13.42. Victrex’s payout ratio is 17,142.86%.

Insider Activity at Victrex

In other news, insider Brendan Connolly bought 980 shares of the company’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were purchased at an average price of GBX 1,019 ($12.75) per share, with a total value of £9,986.20 ($12,495.25). Also, insider Ian Melling purchased 2,000 shares of the firm’s stock in a transaction on Friday, December 13th. The shares were purchased at an average cost of GBX 1,135 ($14.20) per share, with a total value of £22,700 ($28,403.40). Company insiders own 1.64% of the company’s stock.

Victrex Company Profile

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.